M. Ghi

发表

Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.

A. Paccagnella, R. Carnuccio, O. Nascimben, 2004, International journal of radiation oncology, biology, physics.

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19805 patients, on behalf of MACH-NC group.

B. Jeremic, L. Collette, J. Pignon, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Predictive classifier for intensive treatment of head and neck cancer

M. Parmar, J. Pignon, V. Grégoire, 2020, Cancer.

Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study.

A. Paccagnella, A. Bonetti, L. Tomio, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Selection of systemic therapy in patients with locally advanced and recurrent/metastatic head and neck cancer: RAND-based expert opinion by an Italian multidisciplinary panel

M. Benasso, L. Licitra, P. Bonomo, 2020, Tumori.

The role of chemotherapy in locally advanced head and neck squamous cell carcinoma.

A. Paccagnella, E. Cohen, T. Nwizu, 2012, Seminars in radiation oncology.

Role of chemotherapy in 5 000 patients with head and neck cancer treated by curative surgery: a subgroup analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer

J. Pignon, V. Grégoire, Q. Le, 2020 .

Elderly Patients with Small Cell Lung Cancer

A. Paccagnella, F. Oniga, R. Biason, 2002, Tumori.

Predictive classifier for intensive treatment of head and neck cancer

M. Parmar, J. Pignon, V. Grégoire, 2020, Cancer.

Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II–III trial

R. Orecchia, A. Paccagnella, C. Casanova, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19805 patients, on behalf of MACH-NC group.

B. Jeremic, L. Collette, J. Pignon, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Concomitant chemoradiation (CRT) or cetuximab/RT (CET/RT) versus induction Docetaxel/ Cisplatin/5-Fluorouracil (TPF) followed by CRT or CET/RT in patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck (LASCCHN). A randomized phase III factorial study (NCT01086826).

I. Floriani, A. Paccagnella, G. Azzarello, 2014 .

The Slippery Role of Induction Chemotherapy in Head and Neck Cancer: Myth and Reality

C. Franzese, D. Ferrari, J. Fayette, 2020, Frontiers in Oncology.

Therapeutic Intensification and Induction Chemotherapy for High-Risk Locally Advanced Squamous Cell Carcinoma

A. Paccagnella, M. Ghi, 2019, Current Treatment Options in Oncology.

Reply to the letter to the editor 'Concurrent cisplatin and radiotherapy versus cetuximab and radiotherapy, an unsolved problem' by Guler et al.

D. Ferrari, M. Ghi, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Induction chemotherapy before chemoradiotherapy in locally advanced head and neck cancer: the future?

A. Paccagnella, M. Ghi, P. D'Amanzo, 2010, The oncologist.

BRIEF COMMUNICATIONS Randomized Phase III Trial of Neoadjuvant Chemotherapy in Head and Neck Cancer: 10-Year Follow-Up

L. Tomio, P. Zorat, C. Marchiori, 2004 .

Concomitant chemoradiation or RT/cetuximab versus induction TPF followed by chemoradiation or RT/cetuximab in locally advanced head and neck squamous cell carcinoma: A randomized phase III factorial study.

I. Floriani, A. Paccagnella, A. Gava, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer.

J. Pignon, V. Grégoire, J. Bourhis, 2019, Oral oncology.

Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up.

A. Paccagnella, M. C. da Mosto, L. Tomio, 2004, Journal of the National Cancer Institute.

Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis.

B. Jeremic, M. Parmar, J. Pignon, 2021, The Lancet. Oncology.

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.

G. Ceresoli, V. Chiarion Sileni, A. Paccagnella, 2004, Lung cancer.

Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study.

A. Chella, M. Clerici, G. Ceresoli, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory Study

L. Mainardi, F. Caponigro, G. Rinaldi, 2021, Diagnostics.

The efficacy of immunonutrition in improving tolerance to chemoradiotherapy in patients with head and neck cancer, receiving nutritional counseling: study protocol of a randomized, open-label, parallel group, bicentric pilot study

P. Pedrazzoli, E. Cereda, C. Klersy, 2021, Therapeutic advances in medical oncology.

Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus.

R. Dellinger, M. Ranieri, J. Bernier, 2015, Critical reviews in oncology/hematology.

Safety of COVID-19 Vaccine in Patients with Cancer in a High-Volume Comprehensive Cancer Center

V. Zagonel, F. Vianello, M. Gottardi, 2022, The oncologist.

Cetuximab/Radiation Therapy (CET + RT) Versus Concomitant Chemoradiation Therapy (cCHT + RT) With or Without Induction Docetaxel/Cisplatin/5Fluorouracil (TPF) in Locally Advanced Head-and-Neck Squamous Cell Carcinoma (LASCCHN) – Preliminary Results on Toxicity of a Randomized, 2x2 Factorial, Phase I

I. Floriani, R. Orecchia, A. Paccagnella, 2012 .

A Phase 2-3 Study Comparing Concomitant Chemoradiation Therapy (CRT) Versus Cetuximab/RT (CET/RT) With or Without Induction Docetaxel/Cisplatin/5-Fluorouracil (TPF) in Locally-Advanced Head and Neck Squamous Cell Carcinoma (LASCCHN) – Efficacy Results of the GSTTC Italian Study (NCT01086826)

R. Orecchia, A. Paccagnella, F. Bertoni, 2013 .

Concomitant chemoradiation in locally advanced head and neck squamous cell carcinoma: A literature-based meta-analysis on the platinum concomitant chemotherapy.

I. Floriani, A. Paccagnella, D. Garavaglia, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

What is the most effective treatment for head and neck squamous cell carcinoma? An individual patient data network meta-analysis from the MACH-NC and MARCH collaborative groups

M. Parmar, J. Pignon, V. Grégoire, 2017 .

991PDDEFINING BEST PRACTICES ON SUPPORTIVE CARE DURING CHEMO-RADIOTHERAPY FOR HEAD AND NECK CANCER WITH A FORMAL SYSTEMATIC METHODOLOGY.

J. Langendijk, L. Licitra, V. De Sanctis, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase II-III study comparing concomitant chemoradiotherapy (CRT) versus cetuximab/RT (CET/RT) with or without induction docetaxel/cisplatin/5-fluorouracil (TPF) in locally advanced head and neck squamous cell carcinoma (LASCCHN): Efficacy results (NCT01086826).

L. Crinò, I. Floriani, A. Paccagnella, 2013 .

Prognostic role of programmed death ligand 1 (PD-L1) and the immune microenvironment in laryngeal carcinoma.

C. Lanza, G. Ottaviano, G. Marioni, 2020, Oral oncology.